MacroGenics
MGNX • NASDAQ
MacroGenics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric Blasius Risser, with a market cap of $218.6M.
Market Cap$218.6M
Employees339.0
CEOEric Blasius Risser
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
MGN
MacroGenics FAQ
Common questions about MacroGenics
MacroGenics is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $17.4M.
MacroGenics has approximately 339 employees.